Growth Metrics

Glucotrack (GCTK) Shares Outstanding (Weighted Average) (2016 - 2020)

Historic Shares Outstanding (Weighted Average) for Glucotrack (GCTK) over the last 7 years, with Q3 2020 value amounting to $15.4 billion.

  • Glucotrack's Shares Outstanding (Weighted Average) rose 942145.67% to $15.4 billion in Q3 2020 from the same period last year, while for Sep 2020 it was $15.4 billion, marking a year-over-year increase of 942145.67%. This contributed to the annual value of $154.9 million for FY2019, which is 174508.62% up from last year.
  • Per Glucotrack's latest filing, its Shares Outstanding (Weighted Average) stood at $15.4 billion for Q3 2020, which was up 942145.67% from $15.4 billion recorded in Q2 2020.
  • Glucotrack's Shares Outstanding (Weighted Average)'s 5-year high stood at $15.4 billion during Q3 2020, with a 5-year trough of $5.7 million in Q1 2016.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $7.6 million (2018), whereas its average is $1.7 billion.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 532.28% in 2016, then soared by 1019865.59% in 2020.
  • Glucotrack's Shares Outstanding (Weighted Average) (Quarter) stood at $5.8 million in 2016, then rose by 8.58% to $6.3 million in 2017, then surged by 33.59% to $8.4 million in 2018, then soared by 1745.09% to $154.9 million in 2019, then skyrocketed by 9856.79% to $15.4 billion in 2020.
  • Its Shares Outstanding (Weighted Average) was $15.4 billion in Q3 2020, compared to $15.4 billion in Q2 2020 and $181.8 million in Q1 2020.